| 1.79 0.03 (1.7%) | 12-26 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 2.26 | 1-year : | 2.61 |
| Resists | First : | 1.93 | Second : | 2.24 |
| Pivot price | 1.81 |
|||
| Supports | First : | 1.45 | Second : | 1.2 |
| MAs | MA(5) : | 1.84 |
MA(20) : | 1.76 |
| MA(100) : | 1.69 |
MA(250) : | 0 | |
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 36.4 |
D(3) : | 43.9 |
| RSI | RSI(14): 51.5 |
|||
| 52-week | High : | 2.24 | Low : | 0.85 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ OGI ] has closed above bottom band by 45.8%. Bollinger Bands are 83.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 7 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 1.86 - 1.87 | 1.87 - 1.88 |
| Low: | 1.72 - 1.73 | 1.73 - 1.74 |
| Close: | 1.77 - 1.79 | 1.79 - 1.81 |
Organigram Holdings Inc., through its subsidiaries, produces and sells cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including cannabis flowers, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the Edison Cannabis Co., Trail Blazer, SHRED, SHRED'ems, Big Bag O' Buds, and Monjour brands; and cannabis edibles products and concentrates. The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative based products to retailers and wholesalers for adult-use recreational cannabis. It sells its products through online, as well as telephone channels. Organigram Holdings Inc. was founded in 2013 and is headquartered in Moncton, Canada.
Tue, 23 Dec 2025
Organigram Stock Jumps Amid Strategic Moves and Market Shifts - StocksToTrade
Mon, 22 Dec 2025
Organigram: Premium Pivot Signals Further Margin Expansion (NASDAQ:OGI) - Seeking Alpha
Mon, 22 Dec 2025
How Investors May Respond To Organigram Global (TSX:OGI) 2025 Loss And 2026 Revenue Guidance Above CAD 300 Million - Yahoo Finance
Thu, 18 Dec 2025
Organigram Global (OGI) Leads Cannabis Stocks Amid Market Shift - GuruFocus
Tue, 16 Dec 2025
Organigram Global Inc (OGI) Q4 2025 Earnings Call Highlights: Record Revenue and Market ... - Yahoo Finance
Tue, 16 Dec 2025
OrganiGram: Fiscal Q4 Earnings Snapshot - KVUE
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 134 (M) |
| Shares Float | 94 (M) |
| Held by Insiders | 32.3 (%) |
| Held by Institutions | 7.5 (%) |
| Shares Short | 4,890 (K) |
| Shares Short P.Month | 4,960 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.08 |
| Profit Margin | 3.4 % |
| Operating Margin | -3 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 72.4 % |
| Gross Profit (p.s.) | 0.56 |
| Sales Per Share | 1.67 |
| EBITDA (p.s.) | -0.02 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 3 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 179 |
| PEG Ratio | 0 |
| Price to Book value | 0.85 |
| Price to Sales | 1.07 |
| Price to Cash Flow | 87.23 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|